Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism.
Ontology highlight
ABSTRACT: Alterations in macrophage (Mφ) polarization, function, and metabolic signature can foster development of chronic diseases, such as autoimmunity or fibrotic tissue remodeling. Thus, identification of novel therapeutic agents that modulate human Mφ biology is crucial for treatment of such conditions. Herein, we demonstrate that the soluble CD83 (sCD83) protein induces pro-resolving features in human monocyte-derived Mφ biology. We show that sCD83 strikingly increases the expression of inhibitory molecules including ILT-2 (immunoglobulin-like transcript 2), ILT-4, ILT-5, and CD163, whereas activation markers, such as MHC-II and MSR-1, were significantly downregulated. This goes along with a decreased capacity to stimulate alloreactive T cells in mixed lymphocyte reaction (MLR) assays. Bulk RN
SUBMITTER: Peckert-Maier K
PROVIDER: S-EPMC10755915 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA